Why the study?
Adults now outnumber pediatric patients with congenital heart disease, introducing challenges like acquired cardiovascular disease, with guidelines emphasizing obesity as a key modifiable risk factor.
What is the prevalence of obesity in adult congenital heart disease patients?
Meta-Analysis
What is the prevalence of obesity in adult congenital heart disease patients?
This systematic review and meta-analysis aims to determine the prevalence of obesity in adult congenital heart disease patients, a growing demographic at risk for acquired cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
Abstract lacks quantitative obesity prevalence data in ACHD; leaves open burden estimation and requires complete reporting in future analyses.
With advancements in medical care, adult patients now outnumber pediatric patients within the congenital heart disease patient population. This evolving demographic has introduced new clinical challenges, including the emergence of acquired cardiovascular diseases in patients with ACHD (adult congenital heart disease). The European Society of Cardiology's working group on Adult Congenital Heart Disease in 2023 emphasized the need for preventive measures against acquired cardiovascular diseases, particularly highlighting obesity (Body mass index (BMI) ≥30 kg/m2) as a modifiable risk factor [1].
No takes yet. Share an insight, caveat, or question.
Vangedal et al. (2025) conducted a meta-analysis in Adult congenital heart disease. Obesity was evaluated on Prevalence of obesity.
Synapse has enriched 10 related papers. Consider them for comparative context: